Multidrug-resistant acinetobacter baumannii causing necrotizing fasciitis in a pancreas-kidney transplant recipient: A case report

Transplantation

Volumn 94, Issue 6, 2012, Pages

  Clemente, Wanessa Trindade ^a   Sanches, Marcelo Dias ^a   Coutinho, Rosane Luiza ^a   De Oliveira Júnior, Antônio Ribeiro ^a   Lauria, Márcio Weissheimer ^a   Lima, Cristiano Xavier ^a   De Castro Romanelli, Roberta Maia ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BASILIXIMAB; IMIPENEM; LINEZOLID; MEROPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYMYXIN; PREDNISONE; TACROLIMUS; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC SENSITIVITY; CASE REPORT; CONVALESCENCE; DEATH; DEBRIDEMENT; DOPPLER ECHOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOURNIER GANGRENE; GRAFT REJECTION; HEART ARREST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; LETTER; MALE; MULTIDRUG RESISTANCE; NECROTIZING FASCIITIS; PANCREAS GRAFT REJECTION; PRIORITY JOURNAL; RESUSCITATION; SCROTAL PAIN; SCROTAL SWELLING; SEPSIS; SEPTIC SHOCK; TISSUE CULTURE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-INFECTIVE AGENTS; DEBRIDEMENT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FASCIITIS, NECROTIZING; FATAL OUTCOME; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; SEPSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866672069     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318265083b     Document Type: Letter

References (10)

1. Charnot-Katsikas A, Dorafshar AH, Aycock JK, et al. Two cases of necrotizing fasciitis due to Acinetobacter baumannii. J Clin Microbiol 2009; 47: 25-8.
2. Levin AS, Gobara S, Mendes CM, et al. Environmental contamination by multidrugresistant Acinetobacter baumannii in an intensive care unit. Infect Control Hosp Epidemiol 2001; 11: 71-7.
3. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 5: 69-2.
4. Sader HS, Castanheira M, Mendes RE, et al. Dissemination and diversity of metallo-A-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int J Antimicrob Agents 2005; 1: 5-7.
5. Mendes C, Oplustil C, Sakagami E, et al. Antimicrobial susceptibility in intensive care units: MYSTIC Program Brazil 200-2. Braz J Infect Dis 2005; 1: 4-4.
6. Levin AS, Barone AA, Peno J, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrugresistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999; 5: 100-8.
7. Kallel H, Bahloul M, Hergafi L, et al. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents 2006; 4: 36-6.
8. Zavascki AP, Goldani LZ, Li J, et al. Polymyxin B for the treatment of multidrugresistant pathogens: a critical review. J Antimicrob Chemother 2007; 6: 120-6.
9. Kwon KT, Oh WS, Song JH, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007; 3: 52-5.
10. Reddy P, Zembower TR, Ison MG, et al. Carbapenem resistant Acinetobacter baumannii infections after organ transplantation. Transplant Infect Dis 2009; 12: 8-7.